# FDA Approves Generic Drug Application for Sun Pharmaceutical Sun Pharmaceutical Industries Ltd. received FDA approval for ANDA091037 on February 22, 2013, expanding its generic drug portfolio and strengthening its position in the U.S. pharmaceutical market. The approval is expected to enhance the company's generic offerings and drive revenue growth through increased market penetration in this therapeutic segment.